#GoldenCross $SBRA at 20.77 R8 HiLo 62% T1Y 19 hold PE 28.4 DIV 9.25% #Sabra Heal #stocks #trading #finance #market

2019-07-11
21 Views

Golden Cross detected for SBRA (Sabra Health Care RE) at the close price of 20.77. Trading at a 62 % level between the 52week High (23.83) and 52week Low (15.70). The average analyst 1-year target price is 19.0 with an average hold and a score of 0.0.

Golden Cross
8 %
SBRA
20.77
Sabra Health Care RE
HiLo
62.4 %
Support
18.87
Resistance
20.77
50DMA
19.67
200DMA
19.66
52week high
23.83
52week low
15.70
10DMA
20.02
20DMA
19.81
100 Mean
19.28
Volume
1117833
AvgDayVol
1293553
MarketCap
3728235776
EBITDA
481236000
Revenue
598136000
PE
28.41
P2S
6.23
P2B
0.00
Dividend
1.80
Div Ex-Date
2019-05-17 00:00:00

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

HILO Index 140 Current 110.15 MA20 -36.6 Lower 158.86 Upper Bound #stocks #trading #markets #finance
Global Indicators,
Global Indicators,

HILO Index 140 Current 110.15 MA20 -36.6 Lower 158.86 Upper Bound #stocks #trading #markets #finance

Andreas Aigner - 2019-07-16

HILO Index 140 Current 110.15 MA20 -36.6 Lower 158.86 Upper Bound #stocks #trading #markets #finance x

Demark B/S Index 2.89 Avg 24.8 Std 2 Curr #stocks #trading #markets #finance
Global Indicators,
1 views
Global Indicators,
1 views

Demark B/S Index 2.89 Avg 24.8 Std 2 Curr #stocks #trading #markets #finance

Andreas Aigner - 2019-07-16

Demark B/S Index 2.89 Avg 24.8 Std 2 Curr #stocks #trading #markets #finance

50/200 DMA Index 2.77 Avg 4.67 Std 1 Curr #stocks #trading #markets #finance
Global Indicators,
3 views
Global Indicators,
3 views

50/200 DMA Index 2.77 Avg 4.67 Std 1 Curr #stocks #trading #markets #finance

Andreas Aigner - 2019-07-16

50/200 DMA Index 2.77 Avg 4.67 Std 1 Curr #stocks #trading #markets #finance x

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.